Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

BBH Market Vectors Biotech ETF

  • Fund Description

    Market Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors U.S. Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/09/16

    • 30-Day SEC Yield1

      0.36%
    • Total Net Assets

      $499.3M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.40%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/16/2016
  • Portfolio Composition (%)
    as of 02/09/16

    • % of Net Assets
    • Stocks

      100.09
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.09
  • Daily HoldingsDaily Holdings (%) as of 02/09/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    841,240
    73,398,19014.70
    Amgen Inc
    AMGN US
    448,584
    64,219,28512.86
    Celgene Corp
    CELG US
    545,361
    54,808,78110.98
    Biogen Idec Inc
    BIIB US
    126,597
    31,647,9846.34
    Baxalta Inc
    BXLT US
    765,291
    28,147,4035.64
    Alexion Pharmaceuticals Inc
    ALXN US
    172,749
    23,573,3294.72
    Illumina Inc
    ILMN US
    159,221
    22,209,7374.45
    Regeneron Pharmaceuticals Inc
    REGN US
    57,801
    21,153,4324.24
    Biomarin Pharmaceutical Inc
    BMRN US
    302,458
    19,693,0403.94
    Incyte Corp Ltd
    INCY US
    263,159
    19,015,8693.81
    Vertex Pharmaceuticals Inc
    VRTX US
    236,065
    18,918,2493.79
    Quintiles Transnational Holdings Inc
    Q US
    287,427
    16,297,1113.26
    United Therapeutics Corp
    UTHR US
    122,265
    14,588,6602.92
    Qiagen Nv
    QGEN US
    630,599
    12,946,1972.59
    Medivation Inc
    MDVN US
    457,470
    12,886,9302.58
    Grifols Sa
    GRFS US
    830,597
    12,101,7982.42
    Alnylam Pharmaceuticals Inc
    ALNY US
    181,643
    10,756,8982.15
    Isis Pharmaceuticals Inc
    IONS US
    271,283
    8,998,4571.80
    Charles River Laboratories Internationa
    CRL US
    112,440
    7,663,9101.54
    Alkermes Plc
    ALKS US
    224,021
    6,510,0501.30
    Seattle Genetics Inc
    SGEN US
    208,230
    6,046,9991.21
    Cepheid Inc
    CPHD US
    188,307
    5,555,0571.11
    Intercept Pharmaceuticals Inc
    ICPT US
    42,844
    4,022,6230.81
    Bluebird Bio Inc
    BLUE US
    74,409
    3,407,1880.68
    Puma Biotechnology Inc
    PBYI US
    32,286
    1,146,1530.23
    Other/Cash
    --
    --
    -459,594-0.09
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.